This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 788204.

Karolinska Institutet (KI)

Karolinska Institutet (KI) is one of the world’s leading medical universities. Its mission is to contribute to the improvement of human health through research and education. KI accounts for over 40% of the medical academic research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. Since 1901 the Nobel Assembly at KI has selected the Nobel laureates in Physiology or Medicine. The Gendered Innovation Alliance (GINA) at KI is a potential framework for training, knowledge and experience exchange for the successful execution for the inclusion of concepts of sex, gender and diversity as biological and social variables in biomedical research and education. The platform provides an infrastructure for robust and effective dissemination of the sex/gender/diversity methods and tools to a scientific community and other target groups; since these terms interconnect all areas of medical preclinical and clinical research, KI’s Gendered Innovation Alliance is uniquely set to collaborate broadly across disciplines in strategic partnerships together with industry, health care providers and patient organizations.

Contact persons: Karolina Kublickiene, Erika Tanos, Mariano Salazar

Address: SE-171 77 Stockholm